Besides being detected in lung cancer patients in this study, the TP53-p.Glu358Val mutation has been reported in multiple cancer types, such as breast cancer [31], chronic myelomonocytic leukemia [32] and adrenocortical cancer [33]. This evidence concerns the gene TP53 and lung cancer.